A case controlled study of the medium-term effects of nasal CPAP on carotid artery intima-media thickness in obstructive sleep apnoea syndrome

D. Hui, K. W. To, Q. Shang, S. Ng, F. Ko, A. Tung, G. Yip, C. M. Yu (Shatin, Hong Kong)

Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Session: Cardiovascular complications in obstructive sleep apnoea
Session type: Thematic Poster Session
Number: 3701
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Hui, K. W. To, Q. Shang, S. Ng, F. Ko, A. Tung, G. Yip, C. M. Yu (Shatin, Hong Kong). A case controlled study of the medium-term effects of nasal CPAP on carotid artery intima-media thickness in obstructive sleep apnoea syndrome. Eur Respir J 2009; 34: Suppl. 53, 3701

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Functional and clinical correlates of intimal-medial thickness of carotid arteries in obstructive sleep apnea
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004

Moderate sleep apnoea syndrome may increase the intimo-media thickness of carotid artery
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004

Adherence to CPAP treatment in patients with coronary artery disease and obstructive sleep apnoea without sleepiness: a preliminary report from the riccadsa trial
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009

Changes in extracranial arteries in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 69-74
Year: 2005



Clinical and polysomnographic determinants of REM predominant obstructive sleep apnoea and response to treatment in a revascularized coronary artery disease cohort
Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders
Year: 2020

CPAP does not reduce inflammatory biomarkers in coronary artery disease patients with nonsleepy obstructive sleep apnoea: a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017


Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP
Source: Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017
Year: 2017



High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008


Atherosclerosis of the carotid arteries in patients with COPD and obstructive sleep apnea (OSA).
Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Year: 2017

Carotid intima-media thickness (IMT) in obstructive sleep apnea (OSA) patients without comorbidities and in healthy volunteers
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009

Influence of obstructive sleep apnea in coronary artery disease: an 8-years-follow-up
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003

CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Polysomnographic characteristics and cardiac function in coronary artery disease patients with nonsleepy obstructive sleep apnoea
Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Year: 2018



Effect of CPAP treatment on adhesion molecules in coronary artery disease with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial
Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Year: 2020



Long-term effects of cardiac rehabilitation on sleep apnea severity in patients with coronary artery disease
Source: International Congress 2017 – CPAP therapy
Year: 2017


Determinants of enlarged main pulmonary artery diameter in patients with scleroderma and concomitant obstructive sleep apnoea
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018


Severity of oxygen desaturation is predictive of carotid intima-media thickness and aortic stiffness in sleep apnoea patients
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004

Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up
Source: Eur Respir J 2006; 28: 596-602
Year: 2006



Effect of positive airway pressure on diastolic function in coronary artery disease patients with non-sleepy obstructive sleep apnea
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016


Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021